<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000044850">
  <TermName>3-aminopyridine-2-carboxaldehyde thiosemicarbazone</TermName>
  <TermPronunciation>(3-uh-MEE-noh-PEER-ih-deen-2-KAR-bok-SAL-deh-hide THY-oh-SEH-mee KAR-buh-ZONE)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of cancer. It is a type of ribonucleotide reductase inhibitor. Also called 3-AP and Triapine.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000706069" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;3-aminopyridine-2-carboxaldehyde thiosemicarbazone&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000706070" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;3-aminopiridina-2-carboxaldehído tiosemicarbazona&quot;" language="es" id="_4"/>
  <SpanishTermName>3-aminopiridina-2-carboxaldehído tiosemicarbazona</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Es un tipo de inhibidor del ribonucleótido reductasa. También se llama 3-AP y Triapine.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2007-01-17</DateLastModified>
</GlossaryTerm>
